Patent Number: 8,318,171

Title: Neurotoxic oligomers

Abstract: This invention relates to methods and compositions for the treatment or alleviation of Alzheimer's disease and of other conditions related to abnormal protein aggregation. In particular, the invention relates to methods and compositions for the immunotherapy of Alzheimer's disease, Parkinson's disease, and cataract. In one aspect the invention provides a method of prophylaxis, treatment or alleviation of a condition characterized by pathological aggregation and accumulation of a specific protein associated with an immunizing-effective dose of one or more tyrosine cross-linked compounds, and optionally also comprising copper ions complexed to the compound. Alternatively passive immunization against a tyrosine cross-linked compound may be used. Prophylactic or therapeutic compositions and diagnostic methods are also disclosed and claimed.

Inventors: Bush; Ashley (Somerville, MA), Cherny; Robert (Brighton East, AU)

Assignee: Prana Biotechnology Limited

International Classification: A61K 39/395 (20060101)

Expiration Date: 2021-11-27 0:00:00